TECX — Tectonic Therapeutic Balance Sheet
0.000.00%
- $573.06m
- $319.65m
Annual balance sheet for Tectonic Therapeutic, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 28.1 | 36 | 28.8 | 141 | 254 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 28.6 | 37 | 30.9 | 147 | 257 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3.66 | 9.55 | 7.23 | 5.3 | 2.55 |
| Other Long Term Assets | |||||
| Total Assets | 32.9 | 47.2 | 39.4 | 153 | 261 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.12 | 7.84 | 40.9 | 11.6 | 9.67 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 5.23 | 12.2 | 43.4 | 12.1 | 9.71 |
| Redeemable Preferred Stock | |||||
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 27.6 | 35 | -4.01 | 141 | 251 |
| Total Liabilities & Shareholders' Equity | 32.9 | 47.2 | 39.4 | 153 | 261 |
| Total Common Shares Outstanding |